The landscape of the US cardiac pacemaker market is rapidly evolving, with significant shifts anticipated in market share dynamics over the next decade. As cardiovascular disease prevalence continues to rise, the need for advanced cardiac devices is becoming increasingly critical. Current projections indicate that the market, valued at USD 1.176 billion in 2024, will expand to USD 1.955 billion...